Significant association of urinary alpha-1-microglobulin compared to urinary neutrophil gelatinase-associated lipocalin with renal insufficiency in patients with type 2 diabetes

被引:12
作者
Chen, Guangming [1 ]
Shan, Xiaoyun [2 ]
Wang, Huabin [2 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Gen Practice, Sch Med, Jinhua, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Clin Lab, Sch Med, Jinhua, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Jinhua Hosp, Cent Lab, Sch Med, Renming Rd, Jinhua, Zhejiang, Peoples R China
关键词
neutrophil gelatinase‐ associated lipocalin; renal insufficiency; type; 2; diabetes; urinary alpha‐ 1‐ microglobulin;
D O I
10.1111/nep.13851
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim Various studies have reported that urinary neutrophil gelatinase-associated lipocalin (NGAL), an indicator of tubular damage, may be an effective biomarker of renal impairment in patients with diabetes. This study aimed to compare the ability of urinary alpha-1-microglobulin (a traditional tubular damage marker) with NGAL for evaluating renal insufficiency in patients with type-2 diabetes. Methods Urinary albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) were used to determine whether 513 participants with type-2 diabetes had renal dysfunction. Urinary alpha-1-microglobulin-to-creatinine ratio (A1MCR) and NGAL-to-creatinine ratio (NCR) were calculated. Results Although both A1MCR and NCR were significantly higher among participants with renal insufficiency than among participants without renal damage, the difference in A1MCR values between participants with and without renal insufficiency was relatively greater than the difference in NCR values, especially among the male subjects. The correlation of ACR or eGFR with A1MCR was stronger than that of ACR or eGFR with NCR. A1MCR showed a good capability for detecting renal dysfunction (area under the curve = 0.80), its cut-off value was 14.82 mg/g, corresponding to 71.4% sensitivity and 73.1% specificity. The diagnostic efficiency of A1MCR was significantly higher than that of NCR. Conclusion The results indicated that the traditional tubular damage marker A1MCR was more significantly associated with renal insufficiency defined by ACR and/or eGFR and may have a higher diagnostic efficiency compared with the efficiency of NCR in patients with type-2 diabetes.
引用
收藏
页码:400 / 407
页数:8
相关论文
共 35 条
[1]   Methodological issues on the use of urinary alpha-1-microglobuline in epidemiological studies [J].
Andersson, Lena ;
Haraldsson, Borje ;
Johansson, Caroline ;
Barregard, Lars .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (04) :1252-1256
[2]   Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage [J].
Bolignano, Davide ;
Donato, Valentina ;
Coppolino, Giuseppe ;
Campo, Susanna ;
Buemi, Antoine ;
Lacquaniti, Antonio ;
Buemi, Michele .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (03) :595-605
[3]   Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes [J].
de Carvalho, Jose Antonio M. ;
Tatsch, Etiane ;
Hausen, Bruna S. ;
Bollick, Yanai S. ;
Moretto, Maria B. ;
Duarte, Thiago ;
Duarte, Marta M. M. F. ;
Londero, Silvia W. K. ;
Premaor, Melissa O. ;
Comim, Fabio V. ;
Delanghe, Joris R. ;
Moresco, Rafael N. .
CLINICAL BIOCHEMISTRY, 2016, 49 (03) :232-236
[4]   Urinary NGAL measurement: Biological variation and ratio to creatinine [J].
Delanaye, Pierre ;
Rozet, Eric ;
Krzesinski, Jean-Marie ;
Cavalier, Etienne .
CLINICA CHIMICA ACTA, 2011, 412 (3-4) :390-390
[5]   Day-to-day variation of urinary NGAL and rational for creatinine correction [J].
Helmersson-Karlqvist, Johanna ;
Arnlov, Johan ;
Larsson, Anders .
CLINICAL BIOCHEMISTRY, 2013, 46 (1-2) :70-72
[6]   Biomarkers of Renal Disease and Progression in Patients with Diabetes [J].
Hojs, Radovan ;
Ekart, Robert ;
Bevc, Sebastjan ;
Hojs, Nina .
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (05) :1010-1024
[7]   Urinary α1-microglobulin as a marker of nephropathy in type 2 diabetlic Asian subiects in Singapore [J].
Hong, CY ;
Hughes, K ;
Chia, KS ;
Ng, V ;
Ling, SL .
DIABETES CARE, 2003, 26 (02) :338-342
[8]  
International Diabetes Federation, 2015, IFD DIABETES ATLAS
[9]   Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables [J].
Ji, Li-Nong ;
Lu, Ju-Ming ;
Guo, Xiao-Hui ;
Yang, Wen-Ying ;
Weng, Jian-Ping ;
Jia, Wei-Ping ;
Zou, Da-Jin ;
Zhou, Zhi-Guang ;
Yu, De-Min ;
Liu, Jie ;
Shan, Zhong-Yan ;
Yang, Yu-Zhi ;
Hu, Ren-Ming ;
Zhu, Da-Long ;
Yang, Li-Yong ;
Chen, Li ;
Zhao, Zhi-Gang ;
Li, Qi-Fu ;
Tian, Hao-Ming ;
Ji, Qiu-He ;
Liu, Jing ;
Ge, Jia-Pu ;
Shi, Li-Xin ;
Xu, Yan-Cheng .
BMC PUBLIC HEALTH, 2013, 13
[10]   Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency [J].
Levey, Andrew S. ;
Gansevoort, Ron T. ;
Coresh, Josef ;
Inker, Lesley A. ;
Heerspink, Hiddo L. ;
Grams, Morgan E. ;
Greene, Tom ;
Tighiouart, Hocine ;
Matsushita, Kunihiro ;
Ballew, Shoshana H. ;
Sang, Yingying ;
Vonesh, Edward ;
Ying, Jian ;
Manley, Tom ;
de Zeeuw, Dick ;
Eckardt, Kai-Uwe ;
Levin, Adeera ;
Perkovic, Vlado ;
Zhang, Luxia ;
Willis, Kerry .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (01) :84-104